Inventor · disambiguated record
Juan Diaz
Also filed as: DIAZ JUAN · DIAZ JUAN E
13 granted patents·12 pending applications·67 citations·filing 2010–2025
89Inventor score
Top patents by PatentIndex Score
25 records- 0197US11591401B2Anti-CD28 compositionsXENCOR INC·Filed 2021·Granted Feb 28, 2023·19 cites·5 claims
- 0296US11919958B2Anti-CD28 compositionsXENCOR INC·Filed 2021·Granted Mar 5, 2024·9 cites·16 claims
- 0393US8986655B2Compositions, devices, and methods related to prostate-specific membrane antigenWEISS GREGORY A·Filed 2010·Granted Mar 24, 2015·26 cites·18 claims
- 0492US11084863B2Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domainsXENCOR INC·Filed 2018·Granted Aug 10, 2021·7 cites·16 claims
- 0591US11932675B2PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved propertiesGENENTECH INC·Filed 2020·Granted Mar 19, 2024·2 cites·15 claims
- 0690US11618776B2Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domainsXENCOR INC·Filed 2019·Granted Apr 4, 2023·4 cites·7 claims
- 0784US12378326B2Anti-CD28 x anti-PSMA antibodiesXENCOR INC·Filed 2024·Granted Aug 5, 2025·0 cites·30 claims
- 0881US2025388704A1Anti-cd28 x anti-psma antibodiesXENCOR INC·Filed 2025·Application pending·0 cites
- 0979US12365743B2Anti-CD28 x anti-PSMA antibodiesXENCOR INC·Filed 2023·Granted Jul 22, 2025·0 cites·1 claims
- 1077US12448423B2Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domainsXENCOR INC·Filed 2022·Granted Oct 21, 2025·0 cites·14 claims
- 1176US2023322961A1Anti-cd28 x anti-psma antibodiesXENCOR INC·Filed 2023·Application pending·0 cites
- 1275US2023257466A1Anti-cd28 compositionsXENCOR INC·Filed 2022·Application pending·0 cites
- 1373US12139525B2Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domainsXENCOR INC·Filed 2021·Granted Nov 12, 2024·0 cites·13 claims
- 1473US2024294593A1Pd-1 targeted il-15/il-15ralpha fc fusion proteins with improved propertiesGENENTECH INC·Filed 2024·Application pending·0 cites
- 1571US2023265206A1Antibodies against cdcp1 for the treatment and detection of cancerUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1666US2025084179A1Anti-cd28 x anti-trop2 antibodiesXENCOR INC·Filed 2024·Application pending·0 cites
- 1766US2025243279A1Bispecific antibodies that bind to nkp46 and mica/bXENCOR INC·Filed 2024·Application pending·0 cites
- 1865US2023340128A1Anti-cd28 x anti-msln antibodiesXENCOR INC·Filed 2023·Application pending·0 cites
- 1965US2024059786A1Anti-cd28 x anti-trop2 antibodiesXENCOR INC·Filed 2023·Application pending·0 cites
- 2064US2023383012A1Antibodies that bind pd-l1, pd-l2, and/or cd28XENCOR INC·Filed 2023·Application pending·0 cites
- 2164US2025043001A1Anti-cd28 compositionsXENCOR INC·Filed 2024·Application pending·0 cites
- 2259US11603412B2Antibodies against CDCP1 for the treatment and detection of cancerUNIV CALIFORNIA·Filed 2018·Granted Mar 14, 2023·0 cites·20 claims
- 2357US2022135684A1Bispecific antibodies that bind pd-l1 and cd28XENCOR INC·Filed 2021·Application pending·0 cites
- 2453US12006345B2Untargeted and targeted IL-10 Fc-fusion proteinsXENCOR INC·Filed 2020·Granted Jun 11, 2024·0 cites·13 claims
- 2546US10040844B2Proteolytic release of cell surface antigens for phage biopanningUNIV CALIFORNIA·Filed 2015·Granted Aug 7, 2018·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Juan Diaz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →